Results

Total Results: 2,223 records

Showing results for "medications".
Users also searched for: medication reconciliation

21. Public Comment on Draft Recommendation Statement: Medications for Risk Reduction of Primary Breast Cancer in Women | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/announcements/public-comment-draft-recommendation-statement-medications-risk-reduction-primary-breast-cancer-women
    May 13, 2013 - Public Comment on Draft Recommendation Statement: Medications for Risk Reduction of Primary Breast Cancer … Preventive Services Task Force posted today for public comment its draft Recommendation Statement on medications

22. Archived: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/v1-breast-cancer-medications-for-risk-reduction--s
    July 08, 2002 - archived Final Recommendation Statement Breast Cancer: Medications for Risk Reduction

23. U.S. Preventive Services Task Force Issues Draft Recommendation Statement on Interventions for Tobacco Cessation in Adults (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/tobacco-cessation-adults-draft-rec-bulletin.pdf
    June 29, 2020 - More research is needed on the benefits and harms of using medications to help pregnant people quit. … In addition, for adults who are not pregnant, there are FDA-approved medications for quitting tobacco—known … Examples of medications include over-the-counter nicotine patches and gum, as well as prescription medications … Although FDA-approved medications can effectively help non-pregnant adults quit, the evidence is not … clear on the benefits and harms of using these medications during pregnancy.

24. Archived: Evidence Summary: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary27/breast-cancer-medications-for-risk-reduction-2013
    April 15, 2013 - of medications to reduce risk for breast cancer is low in the United States 12 . … Interventions include FDA-approved medications to reduce risk for primary breast cancer. … We requested scientific information packets from manufacturers of medications. … Both medications reduced fractures. … medications, with tamoxifen causing 4 more events per 1000 women than raloxifene in STAR.

25. Zvvry6Wa4Sgj-Ejb3Brcvy (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/zVVRY6wa4Sgj-EJb3BRcVy
    November 01, 2013 - Medications for Risk Reduction of Primary Breast Cancer in Women: U.S. … Preventive Services Task Force (USPSTF) recommendation on the use of medications for breast cancer risk … Medications for risk reduction of primary breast cancer in women: clinical summary of U.S. … MEDICATIONS FOR RISK REDUCTION OF PRIMARY BREAST CANCER IN WOMEN CLINICAL SUMMARY OF U.S. … Both medications reduced breast cancer risk in post- menopausal women.

26. Final Recommendation Statement: Medication Use to Reduce Risk of Breast Cancer | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/announcements/final-recommendation-statement-medication-use-reduce-risk-breast-cancer
    September 03, 2019 - Task Force found that some women at increased risk of breast cancer can benefit from risk-reducing medications … However, women who are not at increased risk should not take these medications.

27. Final Research Plan: Cognitive Impairment in Older Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/cognitive-impairment-in-older-adults-screening
    October 19, 2017 - or dietary supplements: Medications aimed at cardiovascular risk reduction for treatment of vascular … dementia (antiplatelet medications, antihypertension medications, HMG-CoA reductase inhibitors) Nonsteroidal … B vitamins and folate, vitamins C and E, beta-carotene, omega-3 fatty acids) Cessation of medications … that may be contributing to cognitive impairment (e.g., anticholinergic medications, benzodiazepines … (i.e., antipsychotics, antiepileptics, antidepressants, selective serotonin reuptake inhibitors) Medications

28. Draft Research Plan: Serologic Screening for Genital Herpes | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/genital-herpes-serologic-screening
    July 08, 2021 - How effective are antiviral medications in reducing genital HSV-2 viral shedding in asymptomatic adolescents … How effective are antiviral medications and behavioral counseling interventions in reducing future symptomatic … What are the harms of antiviral medications and behavioral counseling interventions for reducing future … HSV serologic tests that are not type specific Interventions KQs 4–6: FDA-approved antiviral medications … comparator KQ 3 (cesarean delivery rate): Screened vs. nonscreened groups KQs 4–6: Antiviral medications

29. U.S. Preventive Services Task Force Issues Final Recommendation Statement on Interventions for Tobacco Cessation in Adults (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/tobacco-cessation-adults-final-rec-bulletin.pdf
    January 19, 2021 - More research is needed on the benefits and harms of using medications to help pregnant people quit. … In addition, for adults who are not pregnant, there are FDA-approved medications for quitting tobacco—known … Examples of medications include over-the-counter nicotine patches and gum, as well as prescription medications … Although FDA-approved medications can effectively help adults who are not pregnant quit, the evidence … is not clear on the benefits and harms of using these medications during pregnancy.

30. U.S. Preventive Services Task Force Recommends That Clinicians Ask All Adults About Tobacco Use and Offer Ways to Quit (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/tobaccofinalrsbulletin.pdf
    September 22, 2015 - All Adults About Tobacco Use and Offer Ways to Quit Evidence shows that behavioral therapies and medications … Food and Drug Administration–approved smoking cessation medications include nicotine replacement therapy … , which is available in a variety of forms such as patches, gums, and lozenges, and the medications … Both intervention types (smoking cessation medications and behavioral interventions) are effective; … The Task Force is calling for more research about the use of smoking cessation medications in pregnant

31. Final Research Plan: Lipid Disorders in Children and Adolescents: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan151/lipid-disorders-in-children-screening
    January 15, 2015 - A subsequent branch leads to treatment (medications, lifestyle modifications), and an arrow from treatment … Does treatment of familial hypercholesterolemia with lifestyle modifications and/or lipid-lowering medications … What are the harms of treatment of familial hypercholesterolemia with medications in children and adolescents … Does treatment of multifactorial dyslipidemia with lifestyle modifications and/or lipid-lowering medications … Does treatment of multifactorial dyslipidemia with lifestyle modifications and/or lipid-lowering medications

32. Archived: Final Research Plan: Lipid Disorders in Children and Adolescents: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan151/lipid-disorders-in-children-screening-july-2016
    January 15, 2015 - A subsequent branch leads to treatment (medications, lifestyle modifications), and an arrow from treatment … Does treatment of familial hypercholesterolemia with lifestyle modifications and/or lipid-lowering medications … What are the harms of treatment of familial hypercholesterolemia with medications in children and adolescents … Does treatment of multifactorial dyslipidemia with lifestyle modifications and/or lipid-lowering medications … Does treatment of multifactorial dyslipidemia with lifestyle modifications and/or lipid-lowering medications

33. Archived: Evidence Summary: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer-medications-for-risk-reduction-2002
    May 06, 2002 - Share to Email Print archived Evidence Summary Breast Cancer: Medications

34. Final Research Plan: Genital Herpes Infection: Serologic Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/genital-herpes-screening
    August 06, 2015 - How effective are oral antiviral medications in reducing genital HSV-2 viral shedding in asymptomatic … How effective are preventive medications and behavioral counseling interventions in reducing neonatal … What are the harms of preventive medications and behavioral counseling interventions for reducing future … What are the harms of preventive medications and behavioral counseling interventions for reducing neonatal … vs. placebo KQ 6b: Oral antiviral medications vs. placebo or no intervention KQs 5, 6: Behavioral

35. Archived: Final Research Plan: Genital Herpes Infection: Serologic Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/genital-herpes-screening-november-2016
    August 06, 2015 - How effective are oral antiviral medications in reducing genital HSV-2 viral shedding in asymptomatic … How effective are preventive medications and behavioral counseling interventions in reducing neonatal … What are the harms of preventive medications and behavioral counseling interventions for reducing future … What are the harms of preventive medications and behavioral counseling interventions for reducing neonatal … vs. placebo KQ 6b: Oral antiviral medications vs. placebo or no intervention KQs 5, 6: Behavioral

36. Clinical Summary: Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/y3mQMyN2Y8mxKvPPXjM6kV
    August 13, 2019 - This includes intensive screening, risk-reducing medications, and risk-reducing mastectomy and salpingo-oophorectomy … Relevant USPSTF Recommendations The USPSTF recommends that clinicians offer to prescribe risk-reducing medications … It recommends against the routine use of medications for risk reduction of primary breast cancer in

37. Draft Research Plan: Cognitive Impairment in Older Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/cognitive-impairment-older-adults
    March 06, 2025 - galantamine, rivastigmine) NMDA (N-methyl-D-aspartate) receptor antagonists (memantine) Cessation of medications … ) Cognitive impairment pharmacotherapies discontinued by the manufacturer (tacrine, aducanumab) Medications … used to treat cerebrovascular disease (e.g., antiplatelet medications, antihypertension medications, … Serious adverse events (e.g., death, serious adverse drug reactions), total adverse reactions from medications

38. Use of Medications to Reduce Risk for Primary Breast Cancer: A Systematic Review of the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/7ZSKduUYHWKe7q_tTY9xbF
    April 01, 2013 - Use of Medications to Reduce Risk for Primary Breast Cancer: A Systematic Review of the USPSTF Use … of Medications to Reduce Risk for Primary Breast Cancer: A Systematic Review for the U.S. … Griffin, MS; and Rongwei Fu, PhD Background: Medications to reduce risk for primary breast cancer are … We requested scientific information packets from manufacturers of medications. … Both medications reduced fractures.

39. Draft Research Plan: Osteoporosis to Prevent Fractures: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/osteoporosis-screening-prevent-fractures
    August 12, 2021 - What is the effectiveness of pharmacotherapy with selected Food and Drug Administration (FDA)–approved medications … What are the harms associated with selected FDA-approved medications? … authors) Studies where less than 50% of the enrolled population includes persons with conditions or medications … , multiple myeloma, chronic kidney disease, rheumatoid arthritis, and lupus Adults taking chronic medications … associated with bone loss, including glucocorticosteroids, select antiepileptic medications, hypogonadism-inducing

40. Final Research Plan: Genital Herpes Infection: Serologic Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/genital-herpes-serologic-screening
    December 02, 2021 - How effective are antiviral medications in reducing genital HSV-2 viral shedding in asymptomatic adolescents … How effective are antiviral medications and behavioral counseling interventions in reducing future symptomatic … What are the harms of antiviral medications and behavioral counseling interventions for reducing future … HSV serologic tests that are not type specific Interventions KQs 4–6: FDA-approved antiviral medications … comparator KQ 3 (cesarean delivery rate): Screened vs. nonscreened groups KQs 4–6: Antiviral medications